Call Options

3 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q1 2024

May 10, 2024

BUY
$13.78 - $18.8 $103,350 - $141,000
7,500 Added 27.27%
35,000 $658,000
Q4 2023

Feb 09, 2024

SELL
$10.95 - $17.32 $327,405 - $517,868
-29,900 Reduced 52.09%
27,500 $396,000
Q3 2023

Nov 09, 2023

BUY
$16.59 - $23.77 $952,266 - $1.36 Million
57,400 New
57,400 $996,000

Others Institutions Holding OGN

About Organon & Co.


  • Ticker OGN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 254,330,000
  • Market Cap $3.75B
  • Description
  • Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...
More about OGN
Track This Portfolio

Track Citigroup Inc Portfolio

Follow Citigroup Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Citigroup Inc, based on Form 13F filings with the SEC.

News

Stay updated on Citigroup Inc with notifications on news.